Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary and Q&A indicate strong operational efficiency through AI, robust cash flow, and strategic enrollment initiatives. Despite some unclear responses, the company shows positive yield improvements and a growing pipeline. The federal shutdown has had no impact, and the company is addressing cost pressures effectively. Overall, these factors suggest a positive market reaction.
Revenue $154 million for Q3, representing 53% year-over-year growth. This growth was attributed to strong billings performance and the continued strength of underlying fundamentals.
Last 12 Months Calculated Billings $624 million, up 50% compared to the same period last year. This reflects the strength of current execution and opportunities in automating healthcare services.
Gross Margin 83% this quarter, up from 79% in Q3 of last year. The improvement reflects the scalability of the technology-driven care model.
Operating Margin 20%, a significant improvement from negative 4% in Q3 last year. This improvement is driven by investments in automation and AI, which are creating operational leverage.
Free Cash Flow $81 million this quarter compared to $28 million in Q3 of 2024. This represents a free cash flow margin of 53%, highlighting operational efficiency and a strong business model.
Eligible Lives Growth in eligible lives contributed to the strong billings performance, reflecting a healthy client base and successful launches of new clients.
Yield Targeted enrollment initiatives doubled enrollees compared to Q3 2024, contributing to strong engagement and excellent yield performance.
Average Selling Price Remained essentially flat for the year, with 48% of eligible lives opting for the new engagement-based pricing model.
Operating Expenses 63% of revenue in Q3, down from 83% in the same quarter last year, demonstrating improved operational efficiency.
Income from Operations $30 million, with a 20% operating margin, a substantial improvement from negative 4% in Q3 2024.
AI care assistant, Robin: Robin is transforming member support by providing 24/7 assistance, recognizing pain flare-ups, and delivering immediate support. It improves member engagement, health outcomes, and cost savings.
Automated movement analysis: Using TrueMotion Computer Vision technology, this feature captures joint angles, symmetry, and endurance to provide objective Hinge scores for joint health.
AI integration in engineering: AI adoption among engineers increased to nearly 100%, boosting code output by 120% and improving developer experience by 32%.
Client growth: Contracted clients increased by 25% year-over-year to 2,560, with strong traction in jumbo clients, federal programs, and fully insured segments.
HingeSelect provider network: Went live with over 3,300 provider locations across all 50 states, covering 86% of lives within the network footprint. Clients representing hundreds of thousands of lives have committed to the program.
Revenue growth: Q3 revenue reached $154 million, a 53% year-over-year increase. Last 12 months calculated billings grew by 50% to $624 million.
Gross margin improvement: Gross margin improved to 83% from 79% in Q3 2024, driven by technology-driven care model scalability.
Free cash flow: Generated $81 million in free cash flow in Q3, up from $28 million in Q3 2024, with a free cash flow margin of 53%.
Expansion of pricing model: 48% of eligible lives have adopted the new engagement-based pricing model, maintaining stable average selling prices.
Capital allocation strategy: Focus on organic growth, targeted M&A opportunities, and returning capital to stockholders while managing stock-based compensation and dilution.
Regulatory Risks: The company acknowledges forward-looking statements are subject to various risks, uncertainties, and assumptions, and refers to SEC filings for detailed risks. This indicates potential regulatory hurdles or compliance challenges.
Market Competition: The company faces competitive pressures, as highlighted by the need to maintain high client retention and win rates. The mention of 'head-to-head win rate' suggests a competitive market environment.
Operational Efficiency Risks: While operational efficiency has improved, the company relies heavily on AI and automation. Any disruption or inefficiency in these systems could impact operations and financial performance.
Client Contracting and Seasonality: The business model is highly dependent on the seasonality of client contracts, particularly in the second half of the year. Delays or failures in finalizing contracts could impact revenue and growth.
Dependence on AI and Technology: The company’s reliance on AI for care delivery, product development, and operational efficiency poses risks if the technology fails or underperforms.
Economic Uncertainty: Although not explicitly mentioned, the company’s performance could be impacted by broader economic uncertainties, given its reliance on client budgets and healthcare spending.
Supply Chain and Provider Network Risks: The success of HingeSelect depends on the provider network, which is still in early stages. Any issues in expanding or maintaining this network could affect service delivery.
Stock-Based Compensation and Dilution: The company is managing stock-based compensation and dilution, but this remains a potential risk area for shareholder value.
Revenue Guidance for Q4 2025: Expected revenue to be in the range of $155 million to $157 million, representing 33% year-over-year growth at the midpoint.
Full Year 2025 Revenue Guidance: Raised revenue guidance to a range of $572 million to $574 million, representing 47% year-over-year growth at the midpoint.
Non-GAAP Income from Operations for Q4 2025: Projected to be $34 million to $36 million, or a 22% margin at the midpoint.
Full Year 2025 Non-GAAP Income from Operations: Expected to be $106 million to $108 million, a 19% margin at the midpoint, up from prior guidance of $77 million to $83 million.
Operational Efficiency Gains: AI initiatives are driving faster-than-expected operational efficiency gains, contributing to improved financial outlook.
HingeSelect Provider Network Expansion: Plans to significantly increase the provider network footprint over the next 12 months, with 86% of lives already within the network footprint.
Client Adoption of HingeSelect: Clients representing hundreds of thousands of eligible lives have committed to HingeSelect, with launches planned for next year. Active discussions with clients representing millions of lives are ongoing.
Market Expansion: Promising preliminary data on the next product and plans to expand market reach while maintaining operational efficiency.
The selected topic was not discussed during the call.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.